Recent events
Recent events tied to this brand in public sources.
Back to profile95 entries · Page 5 of 5
2020
Bayer agrees to draft settlement terms in Roundup cases
A report said Bayer agreed to draft settlement terms with law firms representing tens of thousands of people alleging its Roundup weedkiller causes cancer. The source described the terms as a draft, not a completed settlement.
2020
Bayer partners with Agribazaar on farming projects in India
Bayer said it had partnered with agritech firm Agribazaar for its Better Life Farming projects in India. Agribazaar will provide smallholder farmers with marketplace linkages, while the companies will also work to improve access to crop advice and agricultural technologies.
2020
Bayer partners with XAG to offer agricultural drones
Bayer partnered with China's XAG to offer drones as solutions for crop cultivation; the article says Filipino farmers will have access to drones that map farms or collect crop-growth information remotely.
2020
Jury orders Bayer and BASF to pay damages over dicamba herbicide damage
A U.S. jury found Bayer and BASF liable in a farmer's case alleging that dicamba herbicide produced by the companies drifted onto and severely damaged his peach orchard, and awarded $15 million in actual damages and $250 million in punitive damages. Bayer said it would appeal.
2020
Bayer announces coronavirus-relief donations for China
Bayer announced donations of medicine and additional financial aid worth approximately €1.5 million to support people affected by the novel coronavirus outbreak in China. The donations were to be sent to the Chinese Red Cross.
2020
Bayer China announces donation for Wuhan pandemic response
Bayer China announced a donation of medical supplies and funding worth more than RMB 10 million to the Red Cross Society of China Foundation for Wuhan's COVID-19 prevention and control efforts.
2020
WuXi Biologics Germany agrees to acquire Bayer facility assets
WuXi Biologics Germany is to purchase the facility assets of Bayer's cGMP fill-and-finish biologics manufacturing plant in Leverkusen, Germany. The transaction consideration is to be paid in cash upon completion.
2020
Bayer announces collaboration with Exscientia
Bayer and Exscientia announced a collaboration involving Exscientia's AI-based drug discovery technology; the article describes work on cardiovascular and cancer diseases.
2020
Bayer bids a sharply reduced price for acarbose
In the second round of China’s centralized drug procurement, Bayer bid 5.42 yuan per box for acarbose, less than one-tenth of its previous price.
2019
Bayer appeals Roundup cancer verdict
Bayer said it had asked a US federal appeals court to reverse the $25 million judgment in Edwin Hardeman's case, which concerned his claim that Roundup caused his cancer.
2019
Bayer fined over Supradyn Kids advertising
Hungary's acting Competition Council fined Bayer €20,000 and ordered it to terminate communications for Supradyn Kids supplement products. The Council found that a television ad promoting Supradyn Kids multivitamins involved unfair commercial practices against consumers.
2019
Bayer joins Know Diabetes by Heart as national sponsor
Bayer announced that it had joined the Know Diabetes by Heart initiative, a joint initiative of the American Heart Association and the American Diabetes Association, as a national sponsor.
2019
Bayer launches LifeHub UK
Bayer launched LifeHub UK, a new hub focused on developing artificial-intelligence-enabled imaging solutions for disease detection and data-driven drug discovery.
2019
Australian farmer sues Monsanto over Roundup
NSW farmer Ross Wild filed a lawsuit against Monsanto, alleging that long-term exposure to Roundup caused his non-Hodgkin's lymphoma and that product warnings were inadequate. Bayer Australia said the scientific evidence supported the conclusion that Roundup did not cause the disease.
2013
Bayer sues Glenmark over generic Finacea
Bayer, alongside its subsidiaries Intendis and Intraserv, sued Glenmark after Glenmark filed a US application for a generic version of Finacea. Bayer alleges that Glenmark’s product infringes Finacea’s patent and seeks an order preventing commercialization before patent expiry.